CAMBRIDGE, Ontario, Canada: Septodont, a global pharmaceutical and medical device company specializing in dental pain management, has announced that its Canada-based pharma division, Novocol Pharma, will receive funding of over C$32 million from the Canadian government. The investment is part of a countrywide initiative to advance vaccines and therapeutics for COVID-19 on a national level.
As stated in a press release, the government of Canada had made investments of approximately C$1 billion in industrial research, vaccine and pharmaceutical development, and biomanufacturing capacity by mid-March. In order to further strengthen the private sector in the fight against the global COVID-19 pandemic, it has now made new monies available via its Strategic Innovation Fund.
As announced by Septodont, the investment in Novocol will help support a C$72.6 million project to expand the company’s facilities in Ontario, and this will increase biomanufacturing capacity for fill-finish sterile injectables, including vaccines.
“By creating such capacity and capabilities, Novocol will contribute to strengthening Canada’s preparedness for future pandemics, as well as create skilled jobs and economic development in the country’s biopharmaceutical ecosystem. As a contract development and manufacturing organization, our investment will provide valuable services to support Canadian and foreign biopharmaceutical innovators, starting from clinical trial materials through to commercial scale manufacturing,” Septodont CEO Olivier Schiller commented.
According to Johns Hopkins University, Canada had reported almost one million cases of COVID-19 and about 23,000 related deaths by the beginning of April.
MILAN, Italy: Italy has become the European country worst affected by the COVID-19 outbreak, its confirmed cases of infection currently reaching 74,386, ...
BRNO, Czech Republic: A recent study carried out by scientists from Masaryk University in Brno has suggested that there may be a link between new‐onset ...
GENEVA, Switzerland: The SARS-CoV-2 outbreak is causing significant disruption to dental practice worldwide. Oral health professionals, dental associations ...
GERRARDS CROSS, UK: The British Endodontic Society (BES) intends to fund new research in response to the current SARS-CoV-2 pandemic. Proposals are invited ...
The coronavirus (COVID-19) pandemic is an unprecedented ongoing global health crisis, which has already led to loss of too many lives. Global businesses ...
WUHAN, China: As dean of the School and Hospital of Stomatology of Wuhan University, Prof. Zhuan Bian has had first-hand experience of the working situation...
COVID-19 has had a significant impact on our professional life, yet the aftermath of the pandemic and its consequences for our future are still unclear. ...
In 2001, the concept of the human microbiome was first introduced by Joshua Lederberg. The microbiome consists of the entire genomic heritage of ...
JAKARTA, Indonesia: The Indonesian Medical Association has confirmed that 24 medical professionals have died in the country from COVID-19, six of whom were ...
SACRAMENTO, Calif., U.S.: As a result of the Californian Dental Association’s (CDA) endeavors, dentists have been authorized to administer the COVID-19 ...
Live webinar
Thu. 18 July 2024
8:00 pm EST (New York)
Live webinar
Tue. 6 August 2024
6:00 pm EST (New York)
Live webinar
Tue. 13 August 2024
7:00 pm EST (New York)
Live webinar
Wed. 21 August 2024
9:00 am EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 pm EST (New York)
Live webinar
Mon. 2 September 2024
5:00 am EST (New York)
Live webinar
Tue. 3 September 2024
11:00 am EST (New York)
To post a reply please login or register